Literature DB >> 31614257

Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent.

Zhangxu He1, Hui Qiao1, Feifei Yang1, Wenjuan Zhou1, Yunpeng Gong1, Xinhui Zhang1, Haojie Wang1, Bing Zhao1, Liying Ma2, Hong-Min Liu3, Wen Zhao4.   

Abstract

Potent and safe anticancer drugs research and development are still on the way to human health. In this report, a series of novel thiosemicarbazone derivatives containing indole fragment were designed and synthesized. Most compounds exhibited excellent antiproliferative activity against PC3, MGC803 and EC109 cell lines with low micromolar IC50 (0.14-12μM). Especially, compound 5j can selectively inhibit PC3 cells in three tested tumor cells with IC50 value of 0.14 μM, which may be attributed to a synergistic effect after introducing indole fragment into the TSC structure. Meanwhile, compound 5j displayed more selectivity in PC3 cells toward two normal WPMY-1 and GES-1 cell lines, compared to those of 3-AP and DPC. We also found that 5j can effectively inhibit PC3 cell proliferation, colonization and induce apoptosis. What's more, 5j may significantly suppress migration and invasion by blocking the EMT process but had no effect on cell cycle. Collectively, our findings indicate that 5j with structure of thiosemicarbazone containing indole may serve as a useful anticancer lead for further optimization and development.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; Migration; Proliferation; Selectivity; Thiosemicarbazone

Mesh:

Substances:

Year:  2019        PMID: 31614257     DOI: 10.1016/j.ejmech.2019.111764

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Synthesis and evaluation of iridium(III) complexes on antineoplastic activity against human gastric carcinoma SGC-7901 cells.

Authors:  Li Tian; Yuanyuan Zhang; Huiwen Zhang; Yi Zhou; Wenlong Li; Yuhan Yuan; Jing Hao; Linlin Yang; Yunjun Liu
Journal:  J Biol Inorg Chem       Date:  2021-08-26       Impact factor: 3.358

2.  Enhanced anticancer potency with reduced nephrotoxicity of newly synthesized platin-based complexes compared with cisplatin.

Authors:  Roya Salehi; Selda Abyar; Fatemeh Ramazani; Ali Akbar Khandar; Seyed Abolfazl Hosseini-Yazdi; Jonathan M White; Mahdi Edalati; Houman Kahroba; Mehdi Talebi
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

3.  Anti-inflammatory activity of novel thiosemicarbazone compounds indole-based as COX inhibitors.

Authors:  Íris T T Jacob; Fabiana O S Gomes; Mirelly D S de Miranda; Sinara M V de Almeida; Iranildo J da Cruz-Filho; Christina A Peixoto; Teresinha G da Silva; Diogo R M Moreira; Cristiane M L de Melo; Jamerson F de Oliveira; Maria C A de Lima
Journal:  Pharmacol Rep       Date:  2021-02-15       Impact factor: 3.024

4.  Selective Metal Chelation by a Thiosemicarbazone Derivative Interferes with Mitochondrial Respiration and Ribosome Biogenesis in Candida albicans.

Authors:  Ximeng Duan; Zhiyu Xie; Liying Ma; Xueyang Jin; Ming Zhang; Yuliang Xu; Yue Liu; Hongxiang Lou; Wenqiang Chang
Journal:  Microbiol Spectr       Date:  2022-04-18

5.  Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates.

Authors:  Bing Zhao; Xinhui Zhang; Tingting Yu; Ying Liu; Xiaoling Zhang; Yongfang Yao; Xuejian Feng; Hongmin Liu; Dequan Yu; Liying Ma; Shangshang Qin
Journal:  Acta Pharm Sin B       Date:  2020-07-16       Impact factor: 11.413

6.  Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer's Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis.

Authors:  Sumera Zaib; Rubina Munir; Muhammad Tayyab Younas; Naghmana Kausar; Aliya Ibrar; Sehar Aqsa; Noorma Shahid; Tahira Tasneem Asif; Hashem O Alsaab; Imtiaz Khan
Journal:  Molecules       Date:  2021-10-30       Impact factor: 4.411

7.  Novel [18F]-labeled thiol for the labeling of Dha- or maleimide-containing biomolecules.

Authors:  Mylène Richard; Françoise Hinnen; Bertrand Kuhnast
Journal:  EJNMMI Radiopharm Chem       Date:  2022-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.